Initiation of once daily insulin detemir is not associated with weight gain in patients with type 2 diabetes mellitus: results from an observational study

被引：0
|
作者：
Jean-François Yale
Taner Damci
Marcel Kaiser
Eddy Karnieli
Kamlesh Khunti
Andreas Liebl
Florian MM Baeres
Anne Louise Svendsen
Stuart A Ross
机构：
[1] Royal Victoria Hospital,McGill Nutrition and Food Science Centre
[2] Istanbul University,Department of Endocrinology, Cerrahpasa Medical School, Diabetes and Metabolism
[3] Practice for Internal Medicine and Diabetology,Endocrinology, Diabetes & Metabolism
[4] Rambam Medical Center and Rappaport Faculty of Medicine,Diabetes Research Centre
[5] University of Leicester,Center for Diabetes and Metabolism
[6] m&i-Fachklinik Bad Heilbrunn,undefined
[7] Global Medical Affairs,undefined
[8] Department of Biostatistics & Epidemiology,undefined
[9] University of Calgary,undefined
[10] the SOLVE Study Group,undefined
来源：
Diabetology & Metabolic Syndrome | / 5卷
关键词：
Type 2 diabetes mellitus; Insulin therapy; Weight; Body mass index; Insulin dose; Hypoglycaemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Use of insulin deternir once-daily results in less weight gain compared with the use of NPH insulin, particularly in obese subjects with type 2 diabetes
    Philis-Tsimikas, A.
    Koenen, C.
    Pedersen, C. B.
    Thorsteinsson, B.
    DIABETOLOGIA, 2007, 50 : S404 - S404
  • [42] Initiation of insulin glargine in patients with Type 2 diabetes suboptimally controlled on once- or twice-daily NPH insulin: results from the AT.LANTUS trial
    Fulcher, GR
    Storms, F
    Shutler, S
    Leperlier, C
    Gomis, R
    Davies, M
    DIABETOLOGIA, 2004, 47 : A272 - A272
  • [43] Detemir insulin dose is not associated with weight gain in the French ADAPT™ study
    Le Floch, Jean-Pierre
    Levy, Marc
    Mosnier-Pudar, Helen
    Mira, Reginald
    Laroche, Sylvie
    Esch-Wege, Eveline
    Fontaine, Pierre
    DIABETES, 2007, 56 : A145 - A145
  • [44] Once-daily insulin detemir improves glycemic control and tolerability in patients with type 1 or type 2 diabetes enrolled for 6 months in the PREDICTIVE™ study
    Dornhorst, Anne
    Sreenan, Seamus
    Ackermann, Ralf W.
    Hansen, Jes B.
    DIABETES, 2008, 57 : A583 - A584
  • [45] Diabetes-Related Distress, Insulin Dose, and Age Contribute to Insulin-Associated Weight Gain in Patients With Type 2 Diabetes: Results of a Prospective Study
    Jansen, Henry J.
    Vervoort, Gerald M. M.
    De Haan, Anton F. J.
    Netten, Paetrick M.
    de Grauw, Wim J.
    Tack, Cees J.
    DIABETES CARE, 2014, 37 (10) : 2710 - 2717
  • [46] The safety and effectiveness of once daily detemir in patients with type 2 diabetes previously failing oral agents:the Chinese cohort from SOL-VETM observational study
    潘长玉
    China Medical Abstracts(Internal Medicine), 2013, 30 (01) : 21 - 21
  • [47] Insulin Detemir Reduces Weight Gain as a Result of Reduced Food Intake in Patients With Type 1 Diabetes
    Zachariah, Sunil
    Sheldon, Ben
    Shojaee-Moradie, Fariba
    Jackson, Nicola C.
    Backhouse, Katharine
    Johnsen, Sigurd
    Jones, Richard H.
    Umpleby, A. Margot
    Russell-Jones, David L.
    DIABETES CARE, 2011, 34 (07) : 1487 - 1491
  • [48] Once-daily dosing of insulin detemir is associated with lower risk of hypoglycaemia at similar levels of HbA1c compared to once-daily NPH insulin in subjects with type 1 diabetes mellitus
    Shaw, J. E.
    Larsen, J.
    Pedersen, C. B.
    Tang-Fui, S.
    DIABETOLOGIA, 2008, 51 : S391 - S391
  • [49] Weight change upon initiation of insulin detemir treatment with or without dietary intervention in insulin-naive patients with Type 2 diabetes
    Hollander, P.
    Piletic, M.
    Silver, H. J.
    Andersen, H.
    Hiort, L. C.
    Niswender, K.
    DIABETIC MEDICINE, 2013, 30 : E6 - E6
  • [50] Effect of Once-Daily Detemir vs NPH Insulin on Body Weight and Metabolic Control When Added to OADs in Type 2 Diabetes
    Catrinoiu, Doina
    Veresiu, Ioan Andrei
    Botnariu, Eosefina Gina
    DIABETES, 2009, 58 : A521 - A521
12345